The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,4R)-4-hydroxy-N-[[4-(4-methylthiazol-5-yl)phenyl]methyl]-1-(2,2,2-trifluoroacetyl)pyrrolidine-2-carboxamide ID: ALA5170870
PubChem CID: 167719023
Max Phase: Preclinical
Molecular Formula: C18H18F3N3O3S
Molecular Weight: 413.42
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(F)(F)F)cc1
Standard InChI: InChI=1S/C18H18F3N3O3S/c1-10-15(28-9-23-10)12-4-2-11(3-5-12)7-22-16(26)14-6-13(25)8-24(14)17(27)18(19,20)21/h2-5,9,13-14,25H,6-8H2,1H3,(H,22,26)/t13-,14+/m1/s1
Standard InChI Key: YZPLZOZNVWZFST-KGLIPLIRSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-1.6089 -0.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9188 -0.5620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9651 -1.3858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1822 -0.1904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5079 -0.6424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2445 -0.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9346 -0.7228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6711 -0.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7176 0.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 0.8441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1879 0.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3137 -0.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7735 1.0477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4019 1.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5865 1.6585 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.0275 0.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2909 0.5528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6089 0.7141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4449 0.9307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7375 1.7021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8969 0.2405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3803 -0.4026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5970 -1.1984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3947 -1.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0158 -1.7843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9757 -0.8233 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6113 -2.2050 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.1924 -1.6194 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
2 3 2 0
2 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
10 9 1 0
11 10 2 0
11 12 1 0
13 11 1 0
14 13 2 0
15 14 1 0
10 15 1 0
9 16 2 0
16 17 1 0
17 6 2 0
18 1 1 0
19 18 1 0
19 20 1 6
21 19 1 0
22 21 1 0
1 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
24 28 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.42Molecular Weight (Monoisotopic): 413.1021AlogP: 2.26#Rotatable Bonds: 4Polar Surface Area: 82.53Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.62CX Basic pKa: 2.65CX LogP: 1.07CX LogD: 1.07Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.81Np Likeness Score: -1.11
References 1. de Castro GV, Ciulli A.. (2021) Estimating the cooperativity of PROTAC-induced ternary complexes using 19 F NMR displacement assay., 12 (10.0): [PMID:34778777 ] [10.1039/D1MD00215E ]